Arch Venture Management, LLC Syros Pharmaceuticals, Inc. Transaction History

Arch Venture Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$3.26 - $4.66 $652,000 - $932,000	-200,000 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$8.69 - $14.47 $1.74 Million - $2.89 Million	-200,000 Reduced 50.0%	200,000 $1.77 Million
Q2 2020 Aug 12, 2020	SELL	$5.21 - $11.03 $13.9 Million - $29.4 Million	-2,663,817 Reduced 86.94%	400,000 $4.26 Million
Q1 2020 May 06, 2020	SELL	$4.46 - $9.2 $1.12 Million - $2.3 Million	-250,000 Reduced 7.54%	3,063,817 $18.2 Million
Q4 2019 Feb 05, 2020	SELL	$4.52 - $10.1 $2.45 Million - $5.47 Million	-541,234 Reduced 14.04%	3,313,817 $22.9 Million

Q3 2019 Nov 12, 2019	BUY	$7.14 - $11.65 $27.5 Million - $44.9 Million	3,855,051 New	3,855,051 $40 Million

Ticker SYRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,236,200
Market Cap $127M
Description
Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically def...

Get notified when there are updates to the investment portfolio of Arch Venture Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Arch Venture Management, LLC with notifications on news.